Semler Scientific (SMLR) & SpectraScience (SCIE) Financial Comparison

Semler Scientific (OTCMKTS:SMLR) and SpectraScience (OTCMKTS:SCIE) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Semler Scientific and SpectraScience, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Semler Scientific 0 0 2 0 3.00
SpectraScience 0 0 0 0 N/A

Semler Scientific currently has a consensus price target of $44.00, indicating a potential upside of 19.73%. Given Semler Scientific’s higher probable upside, research analysts clearly believe Semler Scientific is more favorable than SpectraScience.

Volatility & Risk

Semler Scientific has a beta of 0.33, indicating that its share price is 67% less volatile than the S&P 500. Comparatively, SpectraScience has a beta of 2.66, indicating that its share price is 166% more volatile than the S&P 500.


This table compares Semler Scientific and SpectraScience’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Semler Scientific 19.66% -982.53% 74.53%
SpectraScience N/A N/A N/A

Earnings & Valuation

This table compares Semler Scientific and SpectraScience’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Semler Scientific $12.45 million 18.66 -$1.51 million ($0.28) -131.25
SpectraScience N/A N/A -$4.46 million N/A N/A

Semler Scientific has higher revenue and earnings than SpectraScience.

Insider & Institutional Ownership

9.7% of Semler Scientific shares are owned by institutional investors. Comparatively, 0.0% of SpectraScience shares are owned by institutional investors. 13.9% of Semler Scientific shares are owned by insiders. Comparatively, 0.5% of SpectraScience shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.


Semler Scientific beats SpectraScience on 8 of the 10 factors compared between the two stocks.

About Semler Scientific

Semler Scientific, Inc. develops, manufactures, and markets patented products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. Its products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition; and WellChec, a multi-test service platform to evaluate patients with various chronic diseases. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as organizations, including healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry; and other healthcare organizations, such as risk assessment groups and other home healthcare providers. It offers its products through salespersons and distributors. Semler Scientific, Inc. was founded in 2007 and is headquartered in San Jose, California.

About SpectraScience

SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally. It offers WavSTAT3 optical biopsy system to determine whether a colon tissue is normal, pre-cancerous, or cancerous without physically removing tissue from the body; and WavSTAT4 optical biopsy system, a colon diagnostic product that operates by using UV laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer. The company also sells mobile consoles and disposable forceps. In addition, it engages in developing an esophageal diagnosis application for the detection of pre-cancerous and cancerous tissues in various tissues of the body. The company was formerly known as GV Medical, Inc. and changed its name to SpectraScience, Inc. in October 1992. SpectraScience, Inc. was founded in 1983 and is based in San Diego, California.

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit